Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH)

Recruiting

Phase 2 Results N/A

Main Contacts

Name Phone E-mail
Novartis Pharmaceuticals Contact Backup

Other Locations

Name City State Country Status
Novartis Investigative Site New Haven Connecticut United States Recruiting_status_icon